Investor expectations of limited future growth might have le...

Investor expectations of limited future growth might have led to Tonghua Dongbao Pharmaceutical's lower P/E ratio. The reduced possibility of significant share price increases speaks to the company's dimmed earnings outlook, which also contributes to the low P/E.